Tuberculosis in the elderly
P Caraux-Paz, S Diamantis, B de Wazières… - Journal of Clinical …, 2021 - mdpi.com
The tuberculosis (TB) epidemic is most prevalent in the elderly, and there is a progressive
increase in the notification rate with age. Most cases of TB in the elderly are linked to the …
increase in the notification rate with age. Most cases of TB in the elderly are linked to the …
[HTML][HTML] The impact of ageing on natural killer cell function and potential consequences for health in older adults
J Hazeldine, JM Lord - Ageing research reviews, 2013 - Elsevier
Forming the first line of defence against virally infected and malignant cells, natural killer
(NK) cells are critical effector cells of the innate immune system. With age, significant …
(NK) cells are critical effector cells of the innate immune system. With age, significant …
[HTML][HTML] Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy
A Vena, DR Giacobbe, A Di Biagio, M Mikulska… - Clinical Microbiology …, 2020 - Elsevier
Objectives To describe clinical characteristics, management and outcome of individuals with
coronavirus disease 2019 (COVID-19); and to evaluate risk factors for all-cause in-hospital …
coronavirus disease 2019 (COVID-19); and to evaluate risk factors for all-cause in-hospital …
Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial
M Christ-Crain, D Stolz, R Bingisser… - American journal of …, 2006 - atsjournals.org
Rationale: In patients with community-acquired pneumonia, guidelines recommend
antibiotic treatment for 7 to 21 d. Procalcitonin is elevated in bacterial infections, and its …
antibiotic treatment for 7 to 21 d. Procalcitonin is elevated in bacterial infections, and its …
[HTML][HTML] A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal …
HL Platt, JF Cardona, M Haranaka, HI Schwartz… - Vaccine, 2022 - Elsevier
Abstract Background Pneumococcal conjugate vaccines (PCVs) have greatly reduced the
incidence of pneumococcal disease, yet unmet medical need remains due to increased …
incidence of pneumococcal disease, yet unmet medical need remains due to increased …
Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia
B Müller, S Harbarth, D Stolz, R Bingisser… - BMC infectious …, 2007 - Springer
Background Community-acquired pneumonia (CAP) is the most frequent infection-related
cause of death. The reference standard to diagnose CAP is a new infiltrate on chest …
cause of death. The reference standard to diagnose CAP is a new infiltrate on chest …
Denture wearing during sleep doubles the risk of pneumonia in the very elderly
T Iinuma, Y Arai, Y Abe, M Takayama… - Journal of dental …, 2015 - journals.sagepub.com
Poor oral health and hygiene are increasingly recognized as major risk factors for
pneumonia among the elderly. To identify modifiable oral health–related risk factors, we …
pneumonia among the elderly. To identify modifiable oral health–related risk factors, we …
Aging, microglial cell priming, and the discordant central inflammatory response to signals from the peripheral immune system
RN Dilger, RW Johnson - Journal of Leucocyte Biology, 2008 - academic.oup.com
Recent studies suggest that activation of the peripheral immune system elicits a discordant
central (ie, in the brain) inflammatory response in aged but otherwise healthy subjects …
central (ie, in the brain) inflammatory response in aged but otherwise healthy subjects …
Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system
J Chen, JB Buchanan, NL Sparkman… - Brain, behavior, and …, 2008 - Elsevier
Acute cognitive disorders are common in elderly patients with peripheral infections but it is
not clear why. Here, we injected old and young mice with Escherichia coli …
not clear why. Here, we injected old and young mice with Escherichia coli …
Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo …
T Maruyama, O Taguchi, MS Niederman, J Morser… - Bmj, 2010 - bmj.com
Objective To determine the efficacy of a 23-valent pneumococcal polysaccharide vaccine in
people at high risk of pneumococcal pneumonia. Design Prospective, randomised, placebo …
people at high risk of pneumococcal pneumonia. Design Prospective, randomised, placebo …